News

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case, the immune system attacks and destroys the insulin-producing beta ...
Fact checked by Nick Blackmer More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study ...
Recent decades have seen a lot of progress in diabetes treatment. In a new study, Per-Ola Carlsson, Professor of Medical Cell ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
In type 1 diabetes, the immune system attacks the beta cells that produce insulin in your pancreas. The attack causes permanent damage and leaves your pancreas unable to produce insulin.
The older population can benefit from automated insulin delivery systems ... of continuous glucose monitors Type 1 diabetes-related problems predicted by continuous glucose monitors New wearable ...
Beck “Although only a subset of people with type 2 diabetes require insulin, that number still exceeds the number with type 1 diabetes, all of whom use insulin,” Beck told Healio.